Alan L. Landay is a High Senior Professor at Rush University. His research focuses on HIV immunology, infectious diseases, and clinical virology, with particular emphasis on immune responses, virus research, and public health epidemiology. His latest work includes developing and validating a quantitative Orthopoxvirus immunoassay to differentiate serological responses to Mpox infection versus vaccination, and investigating the opposite roles of IL-32 isoforms in promoting vascular calcification in people with HIV. He also leads studies on the effects of pitavastatin on epigenetic aging biomarkers, associations between circulating T cell subsets and endothelial function, and gut microbiome influences on inflammation and cardiovascular profiles in HIV. His recent publications appear in EBioMedicine, Cells, Clinical Infectious Diseases, and The Journal of Infectious Diseases, reflecting his international collaborations in advancing HIV-related cardiovascular and immunological research.
See moreHonors

Experiences

Education
